PROSY vs. MDGL

Last updated Jun 13, 2026

PROSY (Prosus N.V.) and MDGL (Madrigal Pharmaceuticals, Inc.) are both stocks. PROSY operates in Internet Content & Information (Communication Services), while MDGL operates in Biotechnology (Healthcare). Over the past 5 years, PROSY returned -0.56%/yr vs 34.82%/yr for MDGL. At a 0.18 correlation, their price movements are largely independent.

Performance

PROSY vs. MDGL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Prosus N.V. (PROSY) and Madrigal Pharmaceuticals, Inc. (MDGL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PROSY achieves a -26.62% return, which is significantly lower than MDGL's -17.44% return.

PROSY

• 1D: -2.58%
• 1M: -0.11%
• YTD: -26.62%
• 6M: -27.15%
• 1Y: -15.15%
• 3Y*: 10.69%
• 5Y*: -0.56%
• 10Y*: —

MDGL

• 1D: 1.37%
• 1M: -10.95%
• YTD: -17.44%
• 6M: -15.87%
• 1Y: 62.66%
• 3Y*: 21.44%
• 5Y*: 34.82%
• 10Y*: 46.09%

*Multi-year figures are annualized to reflect compound growth (CAGR)

PROSY vs. MDGL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
PROSY Prosus N.V.	-26.62%	55.67%	33.80%	-5.32%	-17.15%	-23.28%	45.77%	-9.97%
MDGL Madrigal Pharmaceuticals, Inc.	-17.44%	88.72%	33.36%	-20.28%	242.52%	-23.77%	22.02%	-9.63%

Correlation

The correlation between PROSY and MDGL is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (5Y) Calculated over the trailing 5-year period	0.18
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019	0.18

Fundamentals

Market Cap PROSY : $101.26B MDGL : $13.96B
EPS PROSY : $1.91 MDGL : -$12.87
PS Ratio PROSY : 7.94 MDGL : 10.21
PB Ratio PROSY : 1.83 MDGL : 25.68
Total Revenue (TTM) PROSY : $12.76B MDGL : $1.13B
Gross Profit (TTM) PROSY : $5.31B MDGL : $1.05B
EBITDA (TTM) PROSY : $10.72B MDGL : -$287.63M

Return for Risk

PROSY vs. MDGL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PROSY

PROSY Risk / Return Rank: 23
PROSY Sharpe Ratio Rank: 19
PROSY Sortino Ratio Rank: 19
PROSY Omega Ratio Rank: 20
PROSY Calmar Ratio Rank: 27
PROSY Martin Ratio Rank: 28

MDGL

MDGL Risk / Return Rank: 78
MDGL Sharpe Ratio Rank: 80
MDGL Sortino Ratio Rank: 80
MDGL Omega Ratio Rank: 77
MDGL Calmar Ratio Rank: 77
MDGL Martin Ratio Rank: 75

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PROSY vs. MDGL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Prosus N.V. (PROSY) and Madrigal Pharmaceuticals, Inc. (MDGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	PROSY	MDGL	Difference
Sharpe ratio: Return per unit of total volatility	-0.53	1.35	-1.88
Sortino ratio: Return per unit of downside risk	-0.60	2.19	-2.79
Omega ratio: Gain probability vs. loss probability	0.93	1.26	-0.33
Calmar ratio: Return relative to maximum drawdown	-0.44	2.11	-2.56
Martin ratio: Return relative to average drawdown	-0.81	4.63	-5.44

PROSY vs. MDGL - Sharpe Ratio Comparison

The current PROSY Sharpe Ratio is -0.53, which is lower than the MDGL Sharpe Ratio of 1.35. The chart below compares the historical Sharpe Ratios of PROSY and MDGL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

PROSY vs. MDGL - Drawdown Comparison

The maximum PROSY drawdown since its inception was -69.36%, smaller than the maximum MDGL drawdown of -98.40%. Use the drawdown chart below to compare losses from any high point for PROSY and MDGL.

Drawdown Indicators

	PROSY	MDGL	Difference
Max Drawdown Largest peak-to-trough decline	-69.36%	-98.40%	+29.04%
Max Drawdown (1Y) Largest decline over 1 year	-39.09%	-29.36%	-9.73%
Max Drawdown (3Y) Largest decline over 3 years	-39.09%	-52.88%	+13.79%
Max Drawdown (5Y) Largest decline over 5 years	-60.96%	-61.41%	+0.45%
Max Drawdown (10Y) Largest decline over 10 years	—	-82.19%	—
Current Drawdown Current decline from peak	-37.79%	-20.25%	-17.54%
Average Drawdown Average peak-to-trough decline	-30.01%	-58.52%	+28.51%
Ulcer Index Depth and duration of drawdowns from previous peaks	21.26%	13.38%	+7.88%

Volatility

PROSY vs. MDGL - Volatility Comparison

Prosus N.V. (PROSY) and Madrigal Pharmaceuticals, Inc. (MDGL) have volatilities of 13.50% and 13.71%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PROSY	MDGL	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.50%	13.71%	-0.21%
Volatility (6M) Calculated over the trailing 6-month period	27.41%	31.76%	-4.35%
Volatility (1Y) Calculated over the trailing 1-year period	32.46%	45.97%	-13.51%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.10%	133.37%	-90.27%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	41.64%	117.49%	-75.85%

Dividends

PROSY vs. MDGL - Dividend Comparison

Neither PROSY nor MDGL has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020
MDGL Madrigal Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PROSY Prosus N.V.	0.00%	0.00%	0.28%	0.25%	0.20%	0.20%	0.12%

Financials

Frequently Asked Questions

Can I hold both PROSY and MDGL in my portfolio?

PROSY and MDGL have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PROSY or MDGL?

MDGL has higher volatility (13.71%) compared to PROSY (13.50%). In terms of maximum drawdown, PROSY dropped -69.36% vs MDGL's -98.40%.

Which has better risk-adjusted returns?

MDGL currently has the higher Sharpe Ratio (1.35 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.